Survival benefit of resection of locally advanced pancreatic cancer following upfront FOLFIRINOX versus FOLFIRINOX only treatment: A propensity score-matched analysis

Autor: Brada, L., Daamen, L., Magermans, L., Walma, M., Latifi, D., van Dam, R., de Hingh, I., Liem, M., de Meijer, V., Patijn, G., Festen, S., Stommel, M., Bosscha, K., Polee, M., Nio, Y., Wessels, F., de Vries, J., van Lienden, K., Bruijnen, R., Busch, O., Koerkamp, B. Groot, van Eijck, C., Molenaar, Q., Wilmink, H., van Santvoort, H., Besselink, M.
Zdroj: In Pancreatology July 2021 21 Supplement 1:S84-S84
Databáze: ScienceDirect